Shares of Dutch specialty chemicals firm Corbion NV advanced on Monday following an upgrade from Berenberg, which moved the stock from a "hold" to a "buy" recommendation and raised its price target to €24 from €19.60. The bank pointed to several factors supporting its more bullish stance, including unprecedented fish oil prices, consolidation opportunity within food ingredients, and what it described as a valuation that is "virtually indistinguishable from bulk chemicals companies."
Berenberg analyst Sebastian Bray highlighted that fish oil prices have surged to record levels above $10 per kilogram in recent months, a move he attributes to the El Niño-driven disruption to Peruvian anchovy catches. Specifically, fish oil with 28% DHA/EPA content reached $10 per kilogram in June 2026, up from $3.10 per kilogram in July 2025. This sharp increase underpins Berenberg's revised forecasts for Corbion's algal business.
Bray raised his algal EBITDA projections to €44 million for 2026 and €49 million for 2027, up from prior estimates of €41 million and €37 million respectively. At the corporate level, Berenberg now models full-year 2026 EBITDA of €207 million on revenues of €1.27 billion, and expects the EBITDA margin to expand to 16.3% from 16.1% in 2025. The broker also lifted its earnings per share estimates to €1.31 for 2026, €1.54 for 2027 and €1.61 for 2028.
On valuation, Bray observed that Corbion currently trades at 7.3x 2026 EV/EBITDA compared with a long-run average multiple of 10x, and said the company is "poised for a rebound towards its historical valuation." Berenberg's sum-of-the-parts exercise assigns an enterprise value of €1.75 billion to Corbion. Within that breakdown, the Sustainable Food Solutions segment is valued at €667 million using a 7.1x EV/EBITDA multiple, while the Incubator and algae segment is assessed at €414 million using a 10.6x multiple.
The broker additionally pointed to precedent transactions to illustrate potential consolidation valuations in the sector, citing IFF's sale of its food ingredients business to CVC for $4.3 billion at 10x EV/EBITDA and Ingredion's proposed takeover of Tate & Lyle at $5 billion at 9x EV/EBITDA. Berenberg also recalled investor commentary and management experience that could support strategic interest; activist investor Jeff Ubben suggested in 2023 that Corbion might be seen as a "strategic asset" by a food industry buyer, and CEO Olivier Rigaud previously oversaw the sale of Naturex to Givaudan in 2018.
On cost and balance sheet metrics, the report notes that Corbion's annual sugar costs are roughly €150 million. Berenberg suggested that lower energy prices could be beneficial through 2026 and into 2027. Net debt stood at €355 million at end-2025, equal to 1.7x EBITDA, and the broker forecasts free cash flow per share of €1.32 for 2026. The report also highlighted currency exposure: about 70% of Corbion's revenues are USD-denominated, and a 1% strengthening of the USD versus the euro would have roughly a $1 million positive impact on EBITDA.
Berenberg's upgrade and higher target were reflected in market moves on Monday as the stock rose. The analyst commentary and updated models underscore how a confluence of higher fish oil prices, potential sector consolidation and modest operational tailwinds could alter Corbion's near-term financial trajectory.
Market context and data points cited in the report
- Fish oil (28% DHA/EPA) price: $10/kg in June 2026, $3.10/kg in July 2025.
- Algal EBITDA: revised to €44m (2026) and €49m (2027) from previous €41m and €37m.
- Full-year 2026 EBITDA: €207m; revenues: €1.27bn; EBITDA margin: 16.3% (2026) vs 16.1% (2025).
- Berenberg EPS: €1.31 (2026), €1.54 (2027), €1.61 (2028).
- Sum-of-the-parts EV: €1.75bn; Sustainable Food Solutions: €667m at 7.1x EV/EBITDA; Incubator & algae: €414m at 10.6x.
- Net debt: €355m at end-2025 (1.7x EBITDA). Free cash flow per share forecast: €1.32 (2026).